Literature DB >> 15050604

Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitis.

Tonino Alonzi1, Ian P Newton, Paul J Bryce, Emma Di Carlo, Giuseppe Lattanzio, Marco Tripodi, Piero Musiani, Valeria Poli.   

Abstract

We have generated mice in which the gene encoding the transcription factor STAT3 can be inactivated in multiple cell types by triggering the endogenous production of type I interferon. Gene inactivation is particularly effective in the liver and the adipose tissue, as well as in macrophages and gut epithelial cells. Upon induction of the mutation, mice develop a wasting syndrome culminating in an aggressive and fatal form of enterocolitis, limited to the large intestine, within 2-3 weeks after the treatment. The disease is characterised by massive infiltration of the gut mucosa by macrophages, granulocytes and CD4+ cells, increased expression of endothelial adhesion molecules and high production of the cytokines interleukin (IL)-6, IL-12, interferon-gamma and IL-10. IL-12 p40 plays a pivotal role in disease development as in vivo treatment with neutralising antibodies completely prevents its onset. Interestingly, oral treatment with wide spectrum antibiotics does not have any effect on either the onset or the development of colitis. Taken together, these data show that STAT3 plays a crucial role in the maintenance of intestinal homeostasis and possibly in mediating specialised cell functions in the intestinal epithelium. Copyright 2004 Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15050604     DOI: 10.1016/j.cyto.2003.12.002

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  35 in total

Review 1.  Novel pathophysiological concepts of inflammatory bowel disease.

Authors:  Toshifumi Hibi; Haruhiko Ogata
Journal:  J Gastroenterol       Date:  2006-01       Impact factor: 7.527

2.  STAT3 genotypic variation and cellular STAT3 activation and colon leukocyte recruitment in pediatric Crohn disease.

Authors:  Tara A Willson; Benjamin R Kuhn; Ingrid Jurickova; Shaina Gerad; David Moon; Erin Bonkowski; Rebecca Carey; Margaret H Collins; Huan Xu; Anil G Jegga; Stephen L Guthery; Lee A Denson
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-07       Impact factor: 2.839

Review 3.  Genetically engineered mouse models for studying inflammatory bowel disease.

Authors:  Atsushi Mizoguchi; Takahito Takeuchi; Hidetomo Himuro; Toshiyuki Okada; Emiko Mizoguchi
Journal:  J Pathol       Date:  2015-11-14       Impact factor: 7.996

Review 4.  A Molecular Link Between Interleukin 22 and Intestinal Mucosal Wound Healing.

Authors:  Xiaoyan Sun; Laura Chalmers; Xiaobing Fu; Min Zhao
Journal:  Adv Wound Care (New Rochelle)       Date:  2012-12       Impact factor: 4.730

5.  STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing.

Authors:  Geethanjali Pickert; Clemens Neufert; Moritz Leppkes; Yan Zheng; Nadine Wittkopf; Moritz Warntjen; Hans-Anton Lehr; Sebastian Hirth; Benno Weigmann; Stefan Wirtz; Wenjun Ouyang; Markus F Neurath; Christoph Becker
Journal:  J Exp Med       Date:  2009-06-29       Impact factor: 14.307

6.  Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling?

Authors:  Andrew Jarnicki; Tracy Putoczki; Matthias Ernst
Journal:  Cell Div       Date:  2010-05-17       Impact factor: 5.130

7.  Corticotropin-Releasing Hormone Receptor 2 Signaling Promotes Mucosal Repair Responses after Colitis.

Authors:  Jill M Hoffman; Stavroula Baritaki; Jonathan J Ruiz; Aristea Sideri; Charalabos Pothoulakis
Journal:  Am J Pathol       Date:  2015-11-18       Impact factor: 4.307

Review 8.  STAT3 signaling in immunity.

Authors:  Emily J Hillmer; Huiyuan Zhang; Haiyan S Li; Stephanie S Watowich
Journal:  Cytokine Growth Factor Rev       Date:  2016-05-09       Impact factor: 7.638

Review 9.  Role of Stat3 in suppressing anti-tumor immunity.

Authors:  Marcin Kortylewski; Hua Yu
Journal:  Curr Opin Immunol       Date:  2008-05-12       Impact factor: 7.486

10.  Activation of an IL-6:STAT3-dependent transcriptome in pediatric-onset inflammatory bowel disease.

Authors:  Rebecca Carey; Ingrid Jurickova; Edgar Ballard; Erin Bonkowski; Xiaonan Han; Huan Xu; Lee A Denson
Journal:  Inflamm Bowel Dis       Date:  2008-04       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.